BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ARNT, HIF1BETA, 405, ENSG00000143437, P27540, HIF-1beta, HIF1B, TANGO AND Treatment
22 results:

  • 1. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
    Liu J; Zhu X; Pan Y; Zhong J; Jin R; Zheng X; Zhang W; Hu K; Ma J; Shi X; Liu H; Yang X; Xu D; Ma C; Chen J; Wang D; Wang X; Li Z; Zhao L; Zhang L; Li T; Liu F; Tan G; Xing B; Zhao H; Zeng Y; Zhang S; Zhang L; Zhou L; Song T; Yang W; Liang X; Xiang B; Xu L; Sun H; Wang K
    Oncologist; 2024 Apr; 29(4):e487-e497. PubMed ID: 37874924
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Selective HIF2A Inhibitors in the Management of Clear Cell Renal cancer and Von Hippel-Lindau-Disease-Associated Tumors.
    Suárez C; Vieito M; Valdivia A; González M; Carles J
    Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The tango between cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in pancreatic cancer.
    Stouten I; van Montfoort N; Hawinkels LJAC
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240052
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia.
    Toledo RA; Jimenez C; Armaiz-Pena G; Arenillas C; Capdevila J; Dahia PLM
    Endocr Rev; 2023 Mar; 44(2):312-322. PubMed ID: 36301191
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The outcome of intravenous and inhalation anesthesia after pancreatic cancer resection: a retrospective study.
    Ren J; Wang J; Chen J; Ma Y; Yang Y; Wei M; Wang Y; Wang L
    BMC Anesthesiol; 2022 May; 22(1):169. PubMed ID: 35637441
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation.
    Healy GM; Salinas-Miranda E; Jain R; Dong X; Deniffel D; Borgida A; Hosni A; Ryan DT; Njeze N; McGuire A; Conlon KC; Dodd JD; Ryan ER; Grant RC; Gallinger S; Haider MA
    Eur Radiol; 2022 Apr; 32(4):2492-2505. PubMed ID: 34757450
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Studying the Anti-Tumor Effects of siRNA Gene Silencing of Some Metabolic Genes in pancreatic Ductal Adenocarcinoma.
    Al Hanjori AS; Alshaer W; Al-Anati B; Wehaibi S; Zihlif M
    Curr Mol Pharmacol; 2021 Oct; 14(4):604-619. PubMed ID: 33045974
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer.
    Fernandez-Garcia D; Hills A; Page K; Hastings RK; Toghill B; Goddard KS; Ion C; Ogle O; Boydell AR; Gleason K; Rutherford M; Lim A; Guttery DS; Coombes RC; Shaw JA
    Breast Cancer Res; 2019 Dec; 21(1):149. PubMed ID: 31856868
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Surgery for cystic tumors of pancreas: Report of high-volume, multicenter Indian experience over a decade.
    Chaudhari VA; Pradeep R; Ramesh H; Bhandare MS; Dhar P; Pal S; Palaniswamy S; Jeswanth S; Menon RN; Singh AN; Sabnis S; Rao GV; Shrikhande SV
    Surgery; 2019 Dec; 166(6):1011-1016. PubMed ID: 31543321
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A score derived from routine biochemical parameters increases the diagnostic accuracy of chromogranin A in detecting patients with neuroendocrine neoplasms.
    Kruljac I; Vurnek I; Maasberg S; Kust D; Blaslov K; Ladika Davidović B; Štefanović M; Demirović A; Bišćanin A; Filipović-Čugura J; Marić Brozić J; Pape UF; Vrkljan M
    Endocrine; 2018 Jun; 60(3):395-406. PubMed ID: 29633144
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification.
    He RQ; Wu PR; Xiang XL; Yang X; Liang HW; Qiu XH; Yang LH; Peng ZG; Chen G
    Int J Mol Med; 2018 May; 41(5):2813-2831. PubMed ID: 29484429
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy.
    Bird NT; Elmasry M; Jones R; Psarelli E; Dodd J; Malik H; Greenhalf W; Kitteringham N; Ghaneh P; Neoptolemos JP; Palmer D
    Br J Surg; 2017 Mar; 104(4):328-336. PubMed ID: 28199010
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma.
    Henriksen SD; Madsen PH; Larsen AC; Johansen MB; Drewes AM; Pedersen IS; Krarup H; Thorlacius-Ussing O
    Clin Epigenetics; 2016; 8():117. PubMed ID: 27891190
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Preoperative risk stratification for major complications following pancreaticoduodenectomy: Identification of high-risk patients.
    Wiltberger G; Muhl B; Benzing C; Atanasov G; Hau HM; Horn M; Krenzien F; Bartels M
    Int J Surg; 2016 Jul; 31():33-9. PubMed ID: 27126297
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Deletion of arnt/HIF1β in pancreatic beta cells does not impair glucose homeostasis in mice, but is associated with defective glucose sensing ex vivo.
    Pillai R; Paglialunga S; Hoang M; Cousteils K; Prentice KJ; Bombardier E; Huang M; Gonzalez FJ; Tupling AR; Wheeler MB; Joseph JW
    Diabetologia; 2015 Dec; 58(12):2832-42. PubMed ID: 26409461
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multiple Pharmacological Properties of a Novel Parthenin Analog P16 as Evident by its Cytostatic and Antiangiogenic Potential Against pancreatic Adenocarcinoma PANC -1 Cells.
    Goswami A; Shah BA; Batra N; Kumar A; Guru SK; Bhushan S; Malik FA; Joshi A; Singh J
    Anticancer Agents Med Chem; 2016; 16(6):771-80. PubMed ID: 26299660
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Binding pancreaticogastrostomy in laparoscopic central pancreatectomy: a novel technique in laparoscopic pancreatic surgery.
    Hong D; Liu Y; Peng S; Sun X; Wang Z; Cheng J; Shen G; Zhang Y; Huang D
    Surg Endosc; 2016 Feb; 30(2):715-720. PubMed ID: 26123326
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Omeprazole Inhibits pancreatic cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway.
    Jin UH; Kim SB; Safe S
    Chem Res Toxicol; 2015 May; 28(5):907-18. PubMed ID: 25826687
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Non-radical resection versus bypass procedure for pancreatic cancer - a consecutive series and systematic review.
    Tol JA; Eshuis WJ; Besselink MG; van Gulik TM; Busch OR; Gouma DJ
    Eur J Surg Oncol; 2015 Feb; 41(2):220-7. PubMed ID: 25511567
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity.
    Hisai H; Kato J; Kobune M; Murakami T; Miyanishi K; Takahashi M; Yoshizaki N; Takimoto R; Terui T; Niitsu Y
    Clin Cancer Res; 2003 Oct; 9(13):4852-9. PubMed ID: 14581357
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.